We intend to
sell every share we purchase for our own profit.
Since you sold 25 shares, we would assume
you sold the shares you purchased first, and report to the IRS that you paid $ 120 + $ 195 for the 25 shares.
Not exact matches
They could then race to
purchase shares in a different marketplace and
sell it back to that investor at $ 20.01.
Capping off 2017, the company say its stock jump 3.9 % when Metro Inc. began
selling back the majority of its Couche - Tard
shares — about $ 1.55 billion worth — to help fund its
purchase of sister drug store chain Jean Coutu Group Inc..
HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000
shares of its common stock, including 1,200,000
shares sold pursuant to the underwriters» full exercise of their option to
purchase additional
shares, at a public offering price of $ 7.50 per
share.
Once the options are exercised and the
shares are
purchased, the CEO can turn around and
sell, pocketing the difference, essentially
sharing in the wealth he or she created for shareholders.
And because private equity isn't easily
sold off once
purchased, investors could be stuck with company
shares for years before seeing a payout.
Fears that Democratic candidate Hilary Clinton would win the election and limit gun sales led to record
purchases last year, but Trump's surprise victory has had a reverse effect, with 2017 sales falling and investors
selling gunmaker
shares.
Many investors know that a put option gives them the right to
sell a stock at a specified price within a set period, while a call option provides the right to
purchase shares at a specified price, also within a set period.
Hence, we can not tell investors to
purchase the
shares, despite today's likely
sell - off,» Tubin and Wooley wrote.
The partnerships and
purchases are a way for Cardinal Health to snag a greater
share of the medical products
sold to hospitals, physicians, and ambulatory centers.
If you are able to
sell your
shares of common stock, you will likely receive less than your
purchase price.
Over the past 6 months 26,000
shares have been
purchased and 670,000
shares have been
sold for a net effect of 644,000 insider
shares sold.
Equity Financing: when a company raises money by
selling its
shares, allowing shareholders to become partial owners of the company through the
purchase of stock.
, this material is for educational purposes only and does not constitute investment advice nor an offer or solicitation to
sell or a solicitation of an offer to buy any
shares of any fund (nor shall any such
shares be offered or
sold to any person) in any jurisdiction in which an offer, solicitation,
purchase or sale would be unlawful under the securities law of that jurisdiction.
Over the past 12 months, there have been 269 thousand insider
shares purchased and 165 thousand insider
shares sold for a net effect of 103 thousand insider
shares purchased.
Insider activity has been minimal over the past twelve months with 32 thousand
shares purchased and 33 thousand
shares sold for a net effect of one thousand
shares purchased.
Furthermore, investors
purchasing shares of our Class A common stock in this offering will only own approximately % of our outstanding
shares of Class A and Class B common stock (and have % of the combined voting power of the outstanding
shares of our Class A and Class B common stock), after the offering even though their aggregate investment will represent % of the total consideration received by us in connection with all initial sales of
shares of our capital stock outstanding as of September 30, 2010, after giving effect to the issuance of
shares of our Class A common stock in this offering and
shares of our Class A common stock to be
sold by certain
selling stockholders.
Obviously, REITs tend to be less favorable since they are required to pay out 90 % of their profits to shareholders vs.
purchasing equities and paying long term capital gains rate when
selling shares.
Pursuant to our equity compensation plans and certain agreements with certain holders of our capital stock, including Jack Dorsey, Jim McKelvey, Khosla Ventures III, LP, entities affiliated with JPMC Strategic Investments, entities affiliated with Sequoia Capital, entities affiliated with Rizvi Traverse, and an entity affiliated with Mary Meeker, including an amended and restated right of first refusal and co-sale agreement, we or our assignees have a right to
purchase shares of our capital stock which stockholders propose to
sell to other parties.
From July 2012 through September 2012, the Registrant
sold an aggregate of 20,164,210
shares of its Series D convertible preferred stock to 21 accredited investors at a
purchase price of approximately $ 11.014 per
share, for an aggregate
purchase price of approximately $ 222.1 million.
Depositors can
purchase and
sell shares through a broker, who often charge commissions, in the secondary markets.
Over the past 12 months, insiders have
purchased 262,000
shares and
sold 401,000
shares for a net effect of 139,000 insider
shares sold.
Concurrently with the reallocation of Fernandez and Tilles» Escrow
Shares, Shkreli caused Fernandez, Tilles and Biestek to enter into agreements with Shkreli (prepared by Retrophin's then outside counsel) whereby Fernandez, Tilles and Biestek agreed to sell 75,000, 37,500, and 37,500 Retrophin shares respectively to Shkreli with payment to follow at a later date (the «Forward Purchase Agreements&ra
Shares, Shkreli caused Fernandez, Tilles and Biestek to enter into agreements with Shkreli (prepared by Retrophin's then outside counsel) whereby Fernandez, Tilles and Biestek agreed to
sell 75,000, 37,500, and 37,500 Retrophin
shares respectively to Shkreli with payment to follow at a later date (the «Forward Purchase Agreements&ra
shares respectively to Shkreli with payment to follow at a later date (the «Forward
Purchase Agreements»).
Mutual funds charge a variety of fees for
purchasing,
selling and holding a
share.
I
purchased shares at 17.38 and
sold CTL180525C00019000 for 24 cents a
share.
In Latin America, for Institutional Investors and Financial Intermediaries Only (Not for public distribution): This material is for educational purposes only and does not constitute an offer or solicitation to
sell or a solicitation of an offer to buy any
shares of any fund (nor shall any such
shares be offered or
sold to any person) in any jurisdiction in which an offer, solicitation,
purchase or sale would be unlawful under the securities law of that jurisdiction.
If the fund's NAV is lower on the day you
sell shares than it was when you
purchased them, you could lose some or all of your initial investment.
DuPont, the chemical company, bought a majority
share in Remington in 1933,
purchased the firearms maker outright in 1980 and then
sold it to an investment firm in New York in 1993.
Under certain circumstances, including if the public offering occurs prior to March 24, 2015, or if the right to
purchase shares in the public offering conflicts with applicable securities laws, or if some other legal impediment or requirement would prevent or materially delay the consummation of or unreasonably interfere with either such offering or the
purchase of the
shares by Passport in such offering, then instead of the right to
purchase shares in the public offering, Passport would have the right to
purchase the same number of
shares, at the same
purchase price the
shares in the public offering are
sold to the public, in a separate and concurrent private placement transaction.
I
sold shares in companies that had run up significantly from my
purchases price.
Worst case I have to
purchase shares at a price lower than market prices when I
sold the put.
For example, Wellington Management may
share non-public client information with brokers and custodian banks in order to buy and
sell securities and record those
purchases and sales accurately.
Insider activity has been minimal over the past twelve months with 260 thousand
shares purchased and 162 thousand
shares sold for a net effect of 98 thousand
shares purchased.
Recently one investor asked me a question whether I would consider
selling covered calls against my recently
purchased shares of Legacy Reserves (LGCY) or not.
The information on this web site or in any communication containing a link to this web site is not intended to constitute investment advice or an offer to
sell, or the solicitation of an offer to
purchase shares or other securities.
He had not
sold or
purchased any
shares in the company between January 17, 2015, and February 11, 2018, according to regulatory findings, ThinkProgress reported.
If you
purchased the stock at $ 75, it drops to $ 68 (
sell automatically executes), then jumps to $ 80 the next week, you lost $ 5 per
share and missed out on the $ 10 per
share upside gain.
In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for,
purchasing and
selling shares of Class A common stock in the open market for the purpose of preventing or retarding a decline in the market price of the Class A common stock while this offering is in progress.
LLC, Deutsche Bank Securities Inc., and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as representatives, will severally agree to
purchase, and we and the
selling stockholders will agree to
sell to them, severally, the number of
shares of Class A common stock indicated below:
In January 2014, we
sold an aggregate of 1,332,640
shares of Series C preferred stock to a total of three accredited investors at a
purchase price per
share of $ 3.40893 for an aggregate
purchase price of $ 4,542,876.
In May 2015, we
sold an aggregate of 1,367,187
shares of Series F preferred stock to a total of four accredited investors at a
purchase price of $ 30.72 for an aggregate
purchase price of $ 41,999,985.
In October 2014, we
sold an aggregate of 2,394,569
shares of Series E preferred stock to a total of two accredited investors at a
purchase price per
share of $ 21.7158 for an aggregate
purchase price of $ 51,999,981.
Between June 2013 and August 2013, the Registrant issued and
sold to six accredited investors an aggregate of 19,433,258
shares of Series D convertible preferred stock, at a
purchase price of $ 2.21 per
share, for aggregate consideration of $ 42,999,970.
We, our officers and directors, and holders of substantially all of the outstanding
shares of our common stock including the
selling stockholders, have agreed with the underwriters, subject to certain exceptions, not to offer,
sell, contract to
sell, pledge, grant any option to
purchase, make any short sale or otherwise dispose of any
shares of common stock, options or warrants to
purchase shares of common stock or securities convertible into, exchangeable for or that represent the right to receive
shares of common stock, whether now owned or hereafter acquired, during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior written consent of each of Goldman, Sachs & Co., Morgan Stanley & Co..
In March 2016, we
sold an aggregate of 334,471
shares of Series F preferred stock to a total of two accredited investors at a
purchase price of $ 30.72 for an aggregate
purchase price of $ 10,274,949.
In May 2016, we
sold an aggregate of 22,780,982
shares of Series F preferred stock to a total of 97 accredited investors at a
purchase price of $ 30.72 for an aggregate
purchase price of $ 699,831,767.
In July 2014, we
sold an aggregate of 1,013,085
shares of Series E preferred stock to a total of five accredited investors at a
purchase price per
share of $ 21.7158 for an aggregate
purchase price of $ 21,999,951.
Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or
purchase, of the
shares may not be circulated or distributed, nor may the
shares be offered or
sold, or be made the subject of an invitation for subscription or
purchase, whether directly or indirectly, to persons in Singapore other than (1) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore, (2) to a relevant person, or any person pursuant to Section 275 (1A), and in accordance with the conditions, specified in Section 275 of the Securities and Futures Act or (3) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the Securities and Futures Act.
In December 2014, we
sold an aggregate of 4,186,629
shares of Series E preferred stock to a total of three accredited investors at a
purchase price of $ 21.7158 per
share for an aggregate
purchase price of $ 90,915,998.